101. Sex of Sexual Partners and Human Papillomavirus Vaccination Among U.S. Girls and Women
- Author
-
Allegra R. Gordon, Sarah M. Peitzmeier, Jennifer Sharpe Potter, Sebastien Haneuse, Madina Agénor, Heather L. McCauley, and S. Bryn Austin
- Subjects
Adult ,Male ,medicine.medical_specialty ,Health Knowledge, Attitudes, Practice ,Adolescent ,Epidemiology ,Sexual Behavior ,Uterine Cervical Neoplasms ,Article ,Odds ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Papillomavirus Vaccines ,Young adult ,Contraception Behavior ,Cervical cancer ,Gynecology ,030505 public health ,business.industry ,Public health ,Papillomavirus Infections ,Vaccination ,Public Health, Environmental and Occupational Health ,Patient Acceptance of Health Care ,medicine.disease ,United States ,Logistic Models ,Sexual Partners ,National Survey of Family Growth ,Multivariate Analysis ,Sexual orientation ,Life course approach ,Female ,0305 other medical science ,business ,Demography - Abstract
Introduction Girls and women are at risk of human papillomavirus (HPV) infection and cervical cancer from male and female sexual partners throughout the life course. However, no study has assessed how sex of sexual partners, a dimension of sexual orientation, may relate to HPV vaccination among girls and women. Methods In 2014, data from the 2006–2010 National Survey of Family Growth were used to conduct logistic regression analyses estimating the relationship between sex of lifetime and past-year sexual partners and HPV vaccine awareness and initiation among U.S. girls and women aged 15–25 years (N=3,253). Results Among U.S. girls and women aged 15–25 years, the prevalence of HPV vaccine awareness and HPV vaccine initiation was 84.4% and 28.5%, respectively. Adjusting for sociodemographic factors, participants with only female past-year sexual partners had significantly lower odds of initiating HPV vaccination relative to those with only male past-year sexual partners (OR=0.16, 95% CI=0.05, 0.55). Similarly, respondents with no lifetime (OR=0.65, 95% CI=0.46, 0.92) or past-year (OR=0.69, 95% CI=0.50, 0.94) sexual partners had significantly lower adjusted odds of HPV vaccine initiation compared with those with only male sexual partners. No difference was apparent in the odds of initiating HPV vaccination between participants with male and female sexual partners and those with only male sexual partners. Conclusions Medical and public health professionals should ensure that girls and women with only female or no sexual partners are included in HPV vaccine education and promotion efforts.
- Published
- 2015